Cargando…
ZNStress: a high-throughput drug screening protocol for identification of compounds modulating neuronal stress in the transgenic mutant sod1G93R zebrafish model of amyotrophic lateral sclerosis
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a lethal neurodegenerative disease with death on average within 2–3 years of symptom onset. Mutations in superoxide dismutase 1 (SOD1) have been identified to cause ALS. Riluzole, the only neuroprotective drug for ALS provides life extension of only...
Autores principales: | McGown, Alexander, Shaw, Dame Pamela J., Ramesh, Tennore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962399/ https://www.ncbi.nlm.nih.gov/pubmed/27460825 http://dx.doi.org/10.1186/s13024-016-0122-3 |
Ejemplares similares
-
Early Interneuron Dysfunction in ALS: Insights from a Mutant sod1 Zebrafish Model
por: McGown, Alexander, et al.
Publicado: (2013) -
Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features
por: Shaw, Matthew P., et al.
Publicado: (2018) -
A new zebrafish model produced by TILLING of SOD1-related amyotrophic lateral sclerosis replicates key features of the disease and represents a tool for in vivo therapeutic screening
por: Da Costa, Marc M. J., et al.
Publicado: (2014) -
Optimised and Rapid Pre-clinical Screening in the SOD1(G93A) Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (ALS)
por: Mead, Richard J., et al.
Publicado: (2011) -
Dysregulation of the complement cascade in the hSOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis
por: Lee, John D, et al.
Publicado: (2013)